Rmb Capital Management, LLC Abiomed Inc Transaction History

Rmb Capital Management, LLC

$4.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$224.73 - $338.64 $674 - $1,015	-3 Reduced 0.18%	1,640 $406,000
Q1 2022 May 06, 2022	SELL	$277.25 - $366.29 $19,962 - $26,372	-72 Reduced 4.2%	1,643 $544,000
Q3 2020 Nov 10, 2020	SELL	$255.22 - $317.0 $38,283 - $47,550	-150 Reduced 8.04%	1,715 $475,000
Q2 2020 Aug 05, 2020	SELL	$141.4 - $257.09 $94,031 - $170,964	-665 Reduced 26.28%	1,865 $451,000
Q1 2020 May 11, 2020	SELL	$130.51 - $196.01 $110,933 - $166,608	-850 Reduced 25.15%	2,530 $367,000
Q4 2019 Feb 13, 2020	SELL	$159.31 - $223.54 $1.33 Million - $1.87 Million	-8,347 Reduced 71.18%	3,380 $577,000
Q3 2019 Nov 12, 2019	SELL	$175.89 - $279.23 $75,632 - $120,068	-430 Reduced 3.54%	11,727 $2.09 Million
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $156,850 - $178,087	-625 Reduced 4.89%	12,157 $3.17 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $77,112 - $101,067	-279 Reduced 2.14%	12,782 $3.65 Million
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $57,059 - $90,182	203 Added 1.58%	13,061 $4.25 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $2.94 Million - $3.73 Million	-8,287 Reduced 39.19%	12,858 $5.78 Million
Q2 2018 Aug 13, 2018	SELL	$278.07 - $446.21 $2.87 Million - $4.61 Million	-10,324 Reduced 32.81%	21,145 $0
Q1 2018 May 14, 2018	SELL	$192.49 - $295.85 $1.13 Million - $1.74 Million	-5,869 Reduced 15.72%	31,469 $9.16 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $1.46 Million - $1.72 Million	-8,631 Reduced 18.78%	37,338 $7 Million
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $576,471 - $668,499	-3,965 Reduced 7.94%	45,969 $7.75 Million
Q2 2017 Aug 14, 2017	BUY	N/A	49,934	49,934 $7.16 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.

Account